Abstract:Retinoic acid receptor beta (RARB) is a transcriptional regulator crucial for coordinating retinoic acid- (RA-) mediated morphogenic movements, cell growth, and differentiation during eye development. Loss- or gain-of-function RARB coding variants have been associated with microphthalmia, coloboma, and anterior segment defects. We identified a de novo variant c.157+1895G>A located within a conserved region (CR1) in the first intron of RARB in an individual with complex microphthalmia and significant global developmental delay. Based on the phenotypic overlap, we further investigated the possible effects of the variant on mRNA splicing and/or transcriptional regulation through in silico and functional studies. In silico analysis identified the possibility of alternative splicing, suggested by one out of three (HSF, SpliceAI, and MaxEntScan) splicing prediction programs, and a strong indication of regulatory function based on publicly available DNase hypersensitivity, histone modification, chromatin folding, and ChIP-seq data sets. Consistent with the predictions of SpliceAI and MaxEntScan, in vitro minigene assays showed no effect on RARB mRNA splicing. Evaluation of CR1 for a regulatory role using luciferase reporter assays in human lens epithelial cells demonstrated a significant increase in the activity of the RARB promoter in the presence of wild-type CR1. This activity was further significantly increased in the presence of CR1 carrying the c.157+1895G>A variant, suggesting that the variant may promote RARB overexpression in human cells. Induction of RARB overexpression in human lens epithelial cells resulted in increased cell proliferation and elevated expression of FOXC1, a known downstream target of RA signaling and a transcription factor whose down- and upregulation is associated with ocular phenotypes overlapping the RARB spectrum. These results support a regulatory role for the CR1 element and suggest that the de novo c.157+1895G>A variant affecting this region may alter the proper regulation of RARB and, as a result, its downstream genes, possibly leading to abnormal development.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: the potential mechanism of a newly emerged non - coding RARB gene variant (c.157 + 1895G > A) associated with complex microphthalmia. Specifically, the researchers wanted to determine whether this variant affects the function of the RARB gene by altering mRNA splicing or transcriptional regulation, which may in turn lead to abnormal eye development and other symptoms of global developmental delay. ### Research Background Retinoic acid receptor beta (RARB) is an important transcriptional regulator that coordinates retinoic acid - mediated morphogenetic movements, cell growth, and differentiation during eye development. Inactivating or activating variants in the coding region of RARB have been found to be associated with microphthalmia, iris coloboma, and anterior segment defects. In this paper, the authors identified a de novo variant (c.157 + 1895G > A) within the conserved region 1 (CR1) of the first intron of the RARB gene in an individual with complex microphthalmia and significant global developmental delay. Based on the phenotypic overlap, the researchers further investigated the possible effects of this variant on mRNA splicing and/or transcriptional regulation. ### Main Research Methods 1. **Variant Identification and Functional Prediction**: The variant was identified through family - based exome sequencing and whole - genome sequencing, and its function was predicted using multiple online tools, including splicing prediction software (such as HSF, SpliceAI, and MaxEntScan) and publicly available chromatin accessibility, histone modification, chromatin folding, and ChIP - seq datasets. 2. **In vitro Functional Studies**: - **Minigene Splicing Experiment**: A minigene containing the variant site was constructed, and its effect on RARB mRNA splicing was detected in vitro - cultured human lens epithelial cells and human embryonic kidney (HEK293) cells. - **Luciferase Reporter Gene Experiment**: The RARB promoter activity in the wild - type and variant conditions in the CR1 region was evaluated. - **RARB Overexpression Experiment**: By overexpressing the RARB gene, the effects on cell proliferation and FOXC1 expression were observed. ### Research Results 1. **Variant Identification and Functional Prediction**: The variant is located in a highly conserved region and shows high conservation across multiple species. Through bioinformatics analysis, it was predicted that this variant may have a regulatory function, but the predictions regarding its splicing effects were inconsistent. 2. **Minigene Splicing Experiment**: The results showed that this variant did not affect the splicing of RARB mRNA. 3. **Luciferase Reporter Gene Experiment**: It was found that the CR1 region significantly enhanced the activity of the RARB promoter in the presence of the variant, indicating that this variant may promote the overexpression of the RARB gene. 4. **RARB Overexpression Experiment**: Overexpression of RARB led to increased cell proliferation and elevated FOXC1 expression levels, supporting the hypothesis that this variant may cause abnormal development by enhancing RARB expression. ### Conclusion This study supports the role of the CR1 element in RARB gene regulation and proposes that the de novo c.157 + 1895G > A variant may cause abnormal expression of downstream genes by changing the normal regulation of RARB, thereby leading to ocular and other developmental abnormalities.

A De Novo Noncoding RARB Variant Associated with Complex Microphthalmia Alters a Putative Regulatory Element

De novo retinoic acid receptor beta (RARB) variant associated with microphthalmia and dystonia

Exonic splice variant discovery using in vitro models of inherited retinal disease

Investigating a possible role of R3HCC1L in embryonic development and ocular disease

The prevalent c.932G>A mutation induces aberrant splicing that can be rescued using splice-shifting antisense oligonucleotides

Loss of the crumbs cell polarity complex disrupts epigenetic transcriptional control and cell cycle progression in the developing retina

A Splicing Mutation in Aryl Hydrocarbon Receptor Associated with Retinitis Pigmentosa.

Pathogenic variants in CRX have distinct cis -regulatory effects on enhancers and silencers in photoreceptors

Temporal and tissue specific regulation of RP-associated splicing factor genes PRPF3, PRPF31 and PRPC8--implications in the pathogenesis of RP

A Leaky Deep Intronic Splice Variant in CLRN1 Is Associated with Non-Syndromic Retinitis Pigmentosa

Whole‐exome Sequencing Identified ARL2 As a Novel Candidate Gene for MRCS (microcornea, Rod‐cone Dystrophy, Cataract, and Posterior Staphyloma) Syndrome

Loss-of-function of RNA-binding protein PRRC2B causes translational defects and congenital cardiovascular malformation

IHH enhancer variant within neighboring NHEJ1 intron causes microphthalmia anophthalmia and coloboma

Monoallelic variants resulting in substitutions of MAB21L1 Arg51 Cause Aniridia and microphthalmia

Dual CRALBP isoforms unveiled: iPSC-derived retinal modeling and AAV2/5-RLBP1 gene transfer raise considerations for effective therapy

A splice acceptor variant in RGS6 associated with intellectual disability, microcephaly, and cataracts disproportionately promotes expression of a subset of RGS6 isoforms

Hypomorphic CDHR1 variants may result in retinitis pigmentosa with relative preservation of cone function

R354X Mutation in PRPF31 Affects Its Capacity in Inflammation Response and Splicing

A novel variant in disrupts ARH3 stability and subcellular localization in children with neurodegeneration and respiratory failure

( ) is a critical early regulator of retinal pigment epithelial development